Richard Helstein

These statements have not been evaluated by the Food and Drug Administration.

[CBS News @CBSNews]

The FDA said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved. https://t.co/vB6lQzijPr

[Richard Helstein @RichardHelstein]

As medcomms become more complex and content‑saturated, 2026 Agency of the Year winner Scientific Global continues to prioritize precision over volume https://t.co/hsTpHscd8k

[Richard Helstein @RichardHelstein]

Not to early to start thinking about BIO International in San Diego, June 22-25! Join 20K+ biotech leaders at the industry's biggest event. Let's connect! #BIO2026 #DrivenbyPurpose

[Richard Helstein @RichardHelstein]

The role of marketing is expanding from storytelling to architecting ... https://t.co/Jol22po3kz

[OpenEvidence @EvidenceOpen]

No one really had a plan for what happens when you give every doctor in America a clinical AI they trust. Turns out they use it. A lot.
On March 10, one million clinical consultations happened between NPI-verified physicians and OpenEvidence in 24 hours.

[Richard Helstein @RichardHelstein]

There will never be another captive-audience advertising opportunity like SkyMall. It had a market cap of $400M in 1998! https://t.co/668v3ysmq1

[Anil Makam @AnilMakam]

1/ A recent trial claims that giving immunotherapy before 3pm doubles survival in advanced lung cancer

Extraordinary claims deserve extraordinary evidence

When paired with multiple red flags, it raises the possibility that the findings are unreliable or worse, fabricated.

🧵

[Richard Helstein @RichardHelstein]

Predictions include Omnicom will be in “defense mode” throughout the year due to clients being unsure of the merger and how it might affect talent disruption within the holding company https://t.co/Zh2S4q7wr9

[Richard Helstein @RichardHelstein]

It's about time bemotrizinol is allowed in US #sunscreen https://t.co/vhNxIk6hq9

[Richard Helstein @RichardHelstein]

The percentage of LinkedIn job postings in the U.S. that include the term “#storyteller” doubled in the past year https://t.co/yUOpkEn6VQ

[Richard Helstein @RichardHelstein]

A new Chinese drug discovery lab merges AI, robotics and chemical engineering to autonomously plan, perform and analyze scientific experiments #pharma #AI https://t.co/EP4yfwbeEd

[Richard Helstein @RichardHelstein]

Incredible story of resiliency & how benign isn't always benign #davidfreyne https://t.co/33u0aFwAZk

[Richard Helstein @RichardHelstein]

As much as we all hate testing in mice & pigs, it's still yielding important results #GeneTherapy https://t.co/mHWx3oJUXH

[Richard Helstein @RichardHelstein]

Chinese #pharma ran about a third of the planet’s #ClinicalTrials last year... https://t.co/NpvInqrVOS

[Richard Helstein @RichardHelstein]

#Agile is out ...Architecture is back. "Design and documentation matter again — not for the intern or the next engineer — but for the machine that will generate the next 10K lines of code" https://t.co/DJm4KV98QJ

[Richard Helstein @RichardHelstein]

@TheCinesthetic

[Richard Helstein @RichardHelstein]

@drteplinsky @OncLive @jhaveri_komal @Dr_RShatsky The sentiment was equally mixed at the AMP conference in Boston today...with an eye towards WGS based MRD approaches

[Richard Helstein @RichardHelstein]

The marketing agency landscape is on the brink of historic change. Brands will need to rethink their approach to sidestep this volatility.

[ADWEEK @Adweek]

Uncertainty in the agency sector will ripple across the marketing ecosystem over the next year, with clients will using this moment of chaos at agencies to rethink their marketing partnership structures. https://t.co/lMbuZHL79U

[Richard Helstein @RichardHelstein]

@BuffaloBills now up 26-3!

[Richard Helstein @RichardHelstein]

@BuffaloBills leading at the half 19-3!